Insider trades
Rachel K. King, Director of Novavax NVAX, has filed 0 purchases and 1 sale on the open market. The latest trade was on 06/20.
Rachel K. King
Director
- Company
- Novavax NVAX
- First filing
- 23/05/22
- Trades
- 24 trades
- Buys / sales
- 0 / 1
- 12-month net buying
- No record
- Last trade
- 06/20
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
NovavaxNVAX | Open-market sale | 24/12/13 | 25/01/02 | 4,150 sh | $9.02 | $37,433 | −21.9% |